Refining pancreatic ductal adenocarcinoma molecular subtype and precision therapeutics with single-nucleus RNA-seq

Refining pancreatic ductal adenocarcinoma molecular subtype and precision therapeutics with single-nucleus RNA-seq

Bibliographic Details
Main Author:	Lishu He
Format:	Article
Language:	English
Published:	BMC 2021-08-01
Series:	BMC Medicine
Online Access:	https://doi.org/10.1186/s12916-021-02052-y

Similar Items

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
by: Apeksha Kakkar, et al.
Published: (2016-12-01)

Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma
by: Shikha Roy, et al.
Published: (2021-01-01)

Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
by: Kai Chen, et al.
Published: (2021-04-01)

The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data
by: Dong Yu, et al.
Published: (2021-05-01)

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
by: Pilar Espiau-Romera, et al.
Published: (2020-12-01)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
by: Hossein Taghizadeh, et al.
Published: (2020-07-01)

Therapeutic Potential of Piperlongumine for Pancreatic Ductal Adenocarcinoma
by: Mohammad, Jiyan Mageed
Published: (2019)

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
by: Markus Glaß, et al.
Published: (2020-06-01)

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
by: Ujjwal Mukund Mahajan, et al.
Published: (2021-07-01)

Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes
by: Rong Liu, et al.
Published: (2021-01-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
by: Justin F. Creeden, et al.
Published: (2020-11-01)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
by: Ruiyu Li, et al.
Published: (2021-07-01)

Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
by: Lan Zhao, et al.
Published: (2018-05-01)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
by: Vikrant Rai, et al.
Published: (2020-11-01)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
by: Ashleigh Parkin, et al.
Published: (2018-11-01)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
by: Ozhan Ocal, et al.
Published: (2015-10-01)

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
by: Yiyin Zhang, et al.
Published: (2018-01-01)

An inflammatory subtype of pancreatic ductal adenocarcinoma is associated with poor prognosis and increased perioperative mortality
by: Christian Benzing, MD, et al.
Published: (2019-09-01)

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
by: Tim D.D. Somerville, et al.
Published: (2018-11-01)

Massively parallel single-nucleus RNA-seq with DroNc-seq
by: Avraham-Davidi, Inbal, et al.
Published: (2018)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
by: Yiqi Yu, et al.
Published: (2021-01-01)

Pathophysiological role of MicroRNA-29 in pancreatic ductal adenocarcinoma
by: Kwon, Jason Jae-Hyuk
Published: (2018)

Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray
by: Haimin Li, et al.
Published: (2016-12-01)

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
by: Daniel R. Principe, et al.
Published: (2021-07-01)

To determine if Globo H is a therapeutic target for pancreatic ductal adenocarcinoma
by: Chia-Yi Yang, et al.
Published: (2013)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Raffaele Pezzilli, et al.
Published: (2011-07-01)

A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma
by: Yuchen Zhang, et al.
Published: (2020-02-01)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
by: Feng Shao, et al.
Published: (2018-06-01)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
by: Vida Karimnia, et al.
Published: (2021-08-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Sohei Satoi
Published: (2021-08-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Apoptotic pathways in pancreatic ductal adenocarcinoma
by: Saur Dieter, et al.
Published: (2008-07-01)

Features of immunophenotype of pancreatic ductal adenocarcinoma
by: A. V. Evseyev
Published: (2014-12-01)

Cell of origin in pancreatic ductal adenocarcinoma
by: Lee, Alex Y. L.
Published: (2017)

Investigating the origins of pancreatic ductal adenocarcinoma
by: Machado de Morais Ferreira, R.
Published: (2015)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
by: Sofia Parrasia, et al.
Published: (2021-01-01)